APA

Giacobbe D. R., Viscoli C., Furfaro E., Colombo A. L. & Del Bono V. (20170126). Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chicago

Giacobbe D R, Viscoli C, Furfaro E, Colombo A L and Del Bono V. 20170126. Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Harvard

Giacobbe D. R., Viscoli C., Furfaro E., Colombo A. L. and Del Bono V. (20170126). Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

MLA

Giacobbe D R, Viscoli C, Furfaro E, Colombo A L and Del Bono V. Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 20170126.